This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Provid Pharmaceuticals Inc.. Active years: 2014-2016.
Company Filing History:
3 out of 3,688 
1 out of 6 Years Active: 2014-2016
Title: John Cardellina: Innovator in Hepatitis C and Cancer Treatment
Introduction
John Cardellina is a notable inventor based in Walkersville, MD (US). He has made significant contributions to the fields of medicine and pharmacology, particularly in the treatment of Hepatitis C and cancer. With a total of 3 patents, Cardellina's work has the potential to impact many lives.
Latest Patents
One of his latest patents is titled "Method of treating HCV infection with a small molecule CHK2 inhibitor." This patent describes a method for treating Hepatitis C Virus infection in a patient by providing a therapeutically effective amount of a specific compound. The compound is defined by a formula that includes a heteroaryl group containing various heteroatoms. Another significant patent is "Use of Chk2 kinase inhibitors for cancer treatment." This patent outlines Chk2-inhibitor compounds and their derivatives, along with methods for treating or preventing diseases and their symptoms using these compounds.
Career Highlights
Throughout his career, John Cardellina has worked with esteemed organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and Provid Pharmaceuticals Inc. His work in these institutions has allowed him to develop innovative solutions to pressing health issues.
Collaborations
Cardellina has collaborated with notable individuals in his field, including Yves Pommier and Robert H Shoemaker. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
John Cardellina's contributions to medical science, particularly in the treatment of Hepatitis C and cancer, highlight his role as an influential inventor. His patents reflect a commitment to improving health outcomes through innovative solutions.